files.nhpri.org - /wordpress/Nhpri_uploads/2020/08/
[To Parent Directory]
8/27/2020 3:06 PM 11061 export-media-urls-112450.CSV
8/18/2020 8:42 PM 20078 export-media-urls-345753.CSV
8/27/2020 3:06 PM 203174 export-media-urls-794831.CSV
8/18/2020 8:34 PM 142782 export-media-urls-891558.CSV
8/18/2020 8:35 PM 183142 export-media-urls-984150.CSV
8/18/2020 8:37 PM 25265 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 42002 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 227746 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 333009 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 310807 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded.pdf
8/18/2020 8:37 PM 21034 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 23700 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 45123 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 55099 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 307550 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded.pdf
8/18/2020 8:37 PM 20935 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 23241 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 42325 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 49477 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 312953 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded.pdf
8/18/2020 8:37 PM 25235 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 41950 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 231695 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 339193 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf.jpg
8/18/2020 8:37 PM 332328 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded.pdf
8/18/2020 8:37 PM 21046 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 23739 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 44809 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 54707 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 312956 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded.pdf
8/18/2020 8:37 PM 24917 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 40317 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 215681 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 311340 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 305064 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded.pdf
8/18/2020 8:37 PM 25402 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 42676 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 237139 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 357385 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 340003 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded.pdf
8/18/2020 8:37 PM 25082 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 41547 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 227364 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 338376 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf.jpg
8/18/2020 8:37 PM 312196 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded.pdf
8/18/2020 8:37 PM 25117 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 41112 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 213053 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 313128 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 309162 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded.pdf
8/18/2020 8:38 PM 25162 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42150 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 232270 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 339821 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 318343 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded.pdf
8/18/2020 8:38 PM 25121 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40839 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 212231 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 308963 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf.jpg
8/18/2020 8:38 PM 312266 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded.pdf
8/18/2020 8:38 PM 24960 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40026 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 214030 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 310343 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 292157 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded.pdf
8/18/2020 8:38 PM 25016 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40946 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 219958 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 320524 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 303297 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded.pdf
8/18/2020 8:38 PM 25067 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40814 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 217845 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 319031 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 310306 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded.pdf
8/18/2020 8:38 PM 25170 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42172 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 229674 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 342137 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 307043 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded.pdf
8/18/2020 8:38 PM 20718 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 23180 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 42597 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 50647 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 309203 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded.pdf
8/18/2020 8:38 PM 25246 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41667 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 226551 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 331073 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 305504 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded.pdf
8/18/2020 8:38 PM 24998 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40987 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 213046 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 309428 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 315783 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded.pdf
8/18/2020 8:38 PM 309587 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-.pdf
8/18/2020 8:38 PM 25192 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41304 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 219489 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 319066 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 25148 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40983 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 221509 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 323981 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 304084 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded.pdf
8/18/2020 8:38 PM 25091 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41006 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 224672 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 325859 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 302790 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded.pdf
8/18/2020 8:38 PM 309037 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-.pdf
8/18/2020 8:38 PM 25084 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41481 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 230062 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 341191 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 24820 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40390 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 220268 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 327656 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 333074 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded.pdf
8/18/2020 8:38 PM 25186 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42973 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 245404 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 362546 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 314161 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded.pdf
8/18/2020 8:38 PM 282092 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-.pdf
8/18/2020 8:38 PM 25142 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41676 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 214359 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 314469 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 285984 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-.pdf
8/18/2020 8:38 PM 25108 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41522 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 210205 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 311722 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 4709 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 7033 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26719 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 35638 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 202280 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded.pdf
8/18/2020 8:38 PM 25138 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41553 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 217941 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 313183 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 326587 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded.pdf
8/18/2020 8:38 PM 25096 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40667 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 218766 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 321714 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 299742 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded.pdf
8/18/2020 8:38 PM 25020 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40800 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 208914 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 303890 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 278384 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded.pdf
8/18/2020 8:38 PM 313114 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-.pdf
8/18/2020 8:38 PM 25073 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41516 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 213183 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 312590 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 4507 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6579 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23975 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31706 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 221458 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded.pdf
8/18/2020 8:38 PM 25214 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42154 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 234371 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 341716 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 313523 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded.pdf
8/18/2020 8:38 PM 25086 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40809 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 219409 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 318240 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 303410 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded.pdf
8/18/2020 8:38 PM 25052 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40715 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 205246 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 305380 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 325312 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded.pdf
8/18/2020 8:38 PM 308791 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-.pdf
8/18/2020 8:38 PM 25001 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40905 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 213746 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 311527 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 25100 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41039 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 223997 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 324294 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 307811 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded.pdf
8/18/2020 8:38 PM 25135 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41130 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 218821 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 327646 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 283058 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded.pdf
8/18/2020 8:38 PM 24992 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40097 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 212403 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 306433 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 309129 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded.pdf
8/18/2020 8:38 PM 20835 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 23190 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 42306 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 50968 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 305568 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded.pdf
8/18/2020 8:38 PM 301639 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-.pdf
8/18/2020 8:38 PM 25045 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41308 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 212931 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 310421 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 25180 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41383 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 217214 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 318075 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 301275 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded.pdf
8/18/2020 8:38 PM 300118 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-.pdf
8/18/2020 8:38 PM 25062 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40926 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 211965 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 312167 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 25114 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40802 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 222328 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 322234 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 309150 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded.pdf
8/18/2020 8:38 PM 6650 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 14261 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 104782 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 151591 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 226212 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded.pdf
8/18/2020 8:38 PM 4607 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6799 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26327 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 34029 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf.jpg
8/18/2020 8:38 PM 234786 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded.pdf
8/18/2020 8:38 PM 4545 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6551 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 24173 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 30322 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 226929 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded.pdf
8/18/2020 8:38 PM 5868 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 10025 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 56368 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 79530 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf.jpg
8/18/2020 8:38 PM 233855 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded.pdf
8/18/2020 8:38 PM 4653 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6958 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26036 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 35330 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 223116 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded.pdf
8/18/2020 8:38 PM 4694 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6891 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26580 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 35594 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 220289 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded.pdf
8/18/2020 8:38 PM 4511 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6610 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23842 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31295 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 223641 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded.pdf
8/18/2020 8:38 PM 4409 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6312 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 22606 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 30517 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 208614 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded.pdf
8/18/2020 8:38 PM 4540 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6657 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23637 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31175 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 220380 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded.pdf
8/18/2020 8:38 PM 4561 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6753 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23640 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31690 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf.jpg
8/18/2020 8:38 PM 223034 UM-ONC_1307-Zejula-niraparib_06262020-cobranded.pdf
8/18/2020 8:38 PM 4551 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6663 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 24258 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31955 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 207085 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded.pdf
8/18/2020 8:38 PM 4576 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6674 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23979 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31949 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 205699 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded.pdf
8/18/2020 8:39 PM 4527 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6569 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23984 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 30627 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 200540 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded.pdf
8/18/2020 8:39 PM 4444 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6348 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23793 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31493 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf.jpg
8/18/2020 8:39 PM 216622 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded.pdf
8/18/2020 8:39 PM 4568 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6606 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24929 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31942 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 227778 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded.pdf
8/18/2020 8:39 PM 4502 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6530 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23823 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31848 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 219451 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded.pdf
8/18/2020 8:39 PM 4516 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6581 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24173 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32272 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf.jpg
8/18/2020 8:39 PM 217274 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded.pdf
8/18/2020 8:39 PM 4569 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6623 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24348 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32190 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 225256 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded.pdf
8/18/2020 8:39 PM 4527 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6602 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23644 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31795 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 236350 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded.pdf
8/18/2020 8:39 PM 4540 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6633 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23950 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31622 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 207117 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded.pdf
8/18/2020 8:39 PM 4605 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6779 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24653 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32188 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 226532 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded.pdf
8/18/2020 8:39 PM 4464 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6516 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24041 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32030 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 208104 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded.pdf
8/18/2020 8:39 PM 4526 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6644 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23530 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31736 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 223575 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded.pdf
8/18/2020 8:39 PM 4562 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6615 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24335 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32017 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 219933 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded.pdf
8/18/2020 8:39 PM 4506 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6535 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23681 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31751 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 222197 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded.pdf
8/18/2020 8:39 PM 4548 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6614 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24155 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32107 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 223780 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded.pdf
8/18/2020 8:39 PM 4540 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6634 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23532 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31782 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:39 PM 224077 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded.pdf
8/18/2020 8:39 PM 4503 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6549 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23925 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31127 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 234971 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded.pdf
8/18/2020 8:39 PM 4529 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6571 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23904 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31886 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 223682 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded.pdf
8/18/2020 8:39 PM 4573 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6651 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24121 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32171 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 217789 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded.pdf
8/18/2020 8:39 PM 4543 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6669 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23499 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32266 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf.jpg
8/18/2020 8:39 PM 237678 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded.pdf
8/18/2020 8:39 PM 4632 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 7068 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 26701 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 35811 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf.jpg
8/18/2020 8:39 PM 219222 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded.pdf
8/18/2020 8:39 PM 4722 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 7027 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 26548 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 35352 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf.jpg
8/18/2020 8:39 PM 227615 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded.pdf
8/18/2020 8:39 PM 4668 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6900 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 26532 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 35879 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf.jpg
8/18/2020 8:39 PM 220073 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded.pdf
8/18/2020 8:37 PM 4573 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6641 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24263 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30325 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 217667 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded.pdf
8/18/2020 8:37 PM 4567 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6628 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24180 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32148 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 226252 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded.pdf
8/18/2020 8:37 PM 4520 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6522 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23882 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32374 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 219556 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded.pdf
8/18/2020 8:37 PM 4527 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6621 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24482 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32577 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 220894 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded.pdf
8/18/2020 8:37 PM 4522 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6579 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24327 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31279 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 224312 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded.pdf
8/18/2020 8:37 PM 4537 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6665 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23359 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31472 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 208826 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded.pdf
8/18/2020 8:37 PM 4518 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6532 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24440 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31470 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf.jpg
8/18/2020 8:37 PM 219029 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded.pdf
8/18/2020 8:37 PM 4524 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6614 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23631 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31085 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 244409 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded.pdf
8/18/2020 8:37 PM 4492 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6504 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23925 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30847 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 220268 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded.pdf
8/18/2020 8:37 PM 4695 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 7019 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 25988 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35081 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf.jpg
8/18/2020 8:37 PM 232650 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded.pdf
8/18/2020 8:37 PM 4627 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6817 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 26285 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35372 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 222287 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded.pdf
8/18/2020 8:37 PM 4628 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6849 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 26482 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35317 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 222468 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded.pdf
8/18/2020 8:37 PM 4540 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6665 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23702 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31677 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 227936 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded.pdf
8/18/2020 8:37 PM 4488 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6951 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 26223 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35585 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf.jpg
8/18/2020 8:37 PM 197618 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded.pdf
8/18/2020 8:37 PM 4559 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6614 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24041 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31886 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 216842 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded.pdf
8/18/2020 8:37 PM 4517 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6586 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23597 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31611 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 223792 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded.pdf
8/18/2020 8:37 PM 4570 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6652 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23845 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31689 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 219428 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded.pdf
8/18/2020 8:37 PM 4496 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6509 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24004 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31623 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 220917 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded.pdf
8/18/2020 8:37 PM 4534 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6600 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23976 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30420 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 221328 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded.pdf
8/18/2020 8:37 PM 4518 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6605 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23940 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30468 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 222700 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded.pdf
8/18/2020 8:37 PM 4569 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6627 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24265 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32112 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 219783 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded.pdf